[1]
Ebiloma, S. et al. 2026. Targeting the P53–Mdm2 Axis In Breast Cancer: Integrating Artificial Intelligence, Multi-Omics, and Natural Compounds to Overcome Therapeutic Resistance. Tropical Journal of Phytochemistry and Pharmaceutical Sciences. 5, 5 (Sep. 2026), 611–620. DOI:https://doi.org/10.26538/tjpps/v5i5.7.